The company is substantially boosted its course of a new therapy for ATTR-CM, utilizing the compound. Initial clinical data reveals significant outcomes for those diagnosed from a serious illness. The effort underscores researchers’ focus to treating critical patient needs in the heart disease field. Attruby: BridgeBio's Novel Approach … Read More